COVID-19 vaccines are not “bad” in the broad sense, but they do carry real, measurable risks that vary by age, sex, and health status. The most common side effects are mild and temporary. Serious reactions exist but are rare, and for most people the risk of harm from a COVID-19 infection is higher than the risk from vaccination. Here’s what the data actually shows.
What the Vaccines Do and How Well They Work
The COVID-19 vaccines available in the U.S. (Pfizer, Moderna, and Novavax) train your immune system to recognize the spike protein on the surface of the SARS-CoV-2 virus. The mRNA vaccines (Pfizer and Moderna) deliver a small strip of genetic instructions that your cells use to build a harmless copy of that protein. Your immune system then learns to fight it. The instructions break down within days. Novavax takes a more traditional approach, delivering the spike protein directly along with an immune-boosting ingredient.
Protection fades over time, which is why updated doses are recommended. The most recent CDC estimates from the 2024-2025 season found that the updated vaccine reduced COVID-related emergency department and urgent care visits by about 33% in adults 18 and older. Against hospitalization in adults 65 and older, effectiveness was 45-46% for people with healthy immune systems and about 40% for those who are immunocompromised. Protection against the most severe outcomes, like ICU admission and death, has historically been higher and longer-lasting than protection against milder illness, though hospitalization rates were too low in the most recent study period to calculate those numbers precisely.
Common Side Effects
Most people who get a COVID-19 vaccine experience some combination of injection site pain or soreness, fatigue, headache, muscle pain, joint pain, chills, and fever. These reactions are signs of your immune system responding and typically resolve within one to three days. Moderna’s vaccine is also associated with nausea and vomiting in some recipients. These side effects are more common after the second dose than the first and tend to be more noticeable in younger adults compared to older ones.
None of these common reactions are dangerous. They can be uncomfortable, but they don’t indicate anything is going wrong.
Rare but Serious Risks
Heart Inflammation
The most widely discussed serious side effect of mRNA vaccines is myocarditis, an inflammation of the heart muscle. This risk is concentrated in young males. Among males aged 12-17, the rate was roughly 63 cases per million second doses. For males aged 18-24, it was about 51 per million. The rate drops sharply with age: males 30 and older saw only about 2-4 cases per million doses. For females of all ages, the risk was far lower, ranging from about 1 to 10 cases per million depending on age group.
Here’s important context: COVID-19 infection itself causes heart inflammation at a higher rate than the vaccine does. A major study comparing the two risks in children and young people found that infection led to roughly 2.24 extra cases of myocarditis or pericarditis per 100,000, compared with 0.85 extra cases per 100,000 after vaccination. The risk from infection was about 3.5 times higher than baseline in the first week after diagnosis, while the vaccine-associated risk was smaller in magnitude and limited to the first four weeks, with no elevated risk detected beyond that window.
Most vaccine-related myocarditis cases, particularly in young people, have been mild and resolved with standard treatment.
Blood Clots
A specific clotting condition called thrombosis with thrombocytopenia syndrome (TTS) was linked to adenovirus-vector vaccines like Johnson & Johnson and AstraZeneca, not to mRNA or protein-based vaccines. The overall rate was about 4 cases per million doses, rising to 14-15 per million among adults aged 30-49. The Johnson & Johnson vaccine is no longer available in the U.S., and AstraZeneca has been withdrawn globally, so this risk is essentially no longer relevant if you’re getting vaccinated today.
Severe Allergic Reactions
Anaphylaxis after the Pfizer vaccine was reported at a rate of about 11 cases per million doses during the initial rollout. This is why vaccination sites ask you to wait 15 minutes after your shot. Anaphylaxis is treatable when caught quickly, and nearly all reported cases were successfully managed on site.
What’s Actually in the Vaccines
The ingredient lists are short. Both Pfizer and Moderna contain mRNA (the active ingredient), lipids (fatty molecules that form a protective bubble around the mRNA so it can enter your cells), salts and buffers to keep the solution at the right pH, and sucrose (table sugar) as a stabilizer. Neither vaccine contains preservatives, and neither leaves residual byproducts. There is no mercury, no aluminum, no fetal tissue, and no microchips. Novavax contains the spike protein itself, lipids, and similar stabilizers.
Pregnancy and Fertility
CDC data from its COVID-19 Vaccine Pregnancy Registry found no safety concerns for pregnant women who received mRNA vaccines or for their babies. Preliminary analyses showed no increase in miscarriage, stillbirth, or birth defects among vaccinated pregnant women compared to expected background rates. There is no evidence that COVID-19 vaccines affect fertility in women or men.
Weighing Vaccine Risk Against Infection Risk
Every medical intervention involves tradeoffs, and COVID-19 vaccines are no exception. The question isn’t whether the vaccines are perfectly risk-free. They aren’t. The question is whether the risks are smaller than the risks of unprotected infection. For nearly every group studied, the answer has been yes.
COVID-19 infection carries its own risks of heart inflammation, blood clots, lung damage, and long COVID, a condition involving persistent fatigue, brain fog, and other symptoms lasting weeks to months. These risks are generally several times higher than the corresponding vaccine risks. For older adults and people with chronic health conditions, the gap between infection risk and vaccine risk is especially wide.
For young, healthy males in their teens and twenties, the risk-benefit calculation is closer because of the elevated myocarditis signal in that group. Even so, the rate of heart inflammation from infection remains higher than from vaccination, and vaccine-associated cases have overwhelmingly been mild.
Your individual risk profile matters. A healthy 20-year-old faces different considerations than a 70-year-old with diabetes. But the broad pattern in the data is consistent: the vaccines cause far less harm than the disease they prevent.